scispace - formally typeset
E

Eugene Braunwald

Researcher at Brigham and Women's Hospital

Publications -  1758
Citations -  278949

Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Determinants of Duration and Mean Rate of Ventricular Ejection

TL;DR: The independent influences of stroke volume, heart rate, aortic pressure, hypothermia, sympathomimetic amines, metered mitral and aortIC valvular regurgitation, and alterations in myocardial contractility on the duration and mean rate of ventricular ejection and filling were studied.
Journal ArticleDOI

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.

TL;DR: In this article, an oral factor Xa inhibitor with 50% renal clearance was compared to well-managed warfarin for stroke or systemic embolism prevention and reduced bleeding in patient.
Journal ArticleDOI

Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure

TL;DR: It is suggested that the adrenergic nervous system plays an important compensatory role in the circulatory adjustments of patients to congestive heart failure, and the need for caution in the use of highly effective antiadrenergic drugs in the treatment of patients with limited cardiac reserve is emphasized.
Journal ArticleDOI

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

TL;DR: Increased concentrations of BNP at initial presentation of patients with STEMI are associated with impaired reperfusion after fibrinolysis and higher short-term risk of mortality, and support the value of combining markers of hemodynamic stress with traditional approaches to risk assessment in acute myocardial infarction.
Journal ArticleDOI

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

TL;DR: The TIMI Risk Score is a simple clinical tool for risk assessment that may aid in the early identification of patients who should be considered for treatment with potent antiplatelet therapy.